Status:
COMPLETED
National Prevalence and Impact of Noninvasive Prenatal Testing
Lead Sponsor:
Obstetrix Medical Group
Conditions:
Aneuploidy
Eligibility:
FEMALE
18-60 years
Brief Summary
Information on pregnant women undergoing non-invasive prenatal testing (NIPT) at one of the Obstetrix Medical Groups Outpatient Centers between January 2012 and June 2014 will be retrospectively gathe...
Detailed Description
Information regarding the frequency of non-invasive testing (NIPT), the impact of screening on the need for and frequency of invasive testing, and the indications for testing are important for the cli...
Eligibility Criteria
Inclusion
- Pregnant Women
- Presented to a participating Obstetrix Outpatient Center for an invasive prenatal diagnostic testing for fetal karyotype (IDTFK) (i.e. amniocentesis or CVS).
- Invasive prenatal diagnostic testing for fetal karyotype (IDTFK) (i.e. amniocentesis or CVS) performed between January 2012 and June 2014 (A control group enrolled between January 2010 - July 2010)
Exclusion
- Patient less than 18 years of age
- Patients not receiving a invasive prenatal diagnostic testing for fetal karyotype (IDTFK)(i.e. amniocentesis or CVS) at a participating study center
- Testing NOT done within the window for inclusion (Jan 2012 - June 2014) or Control Group window (January 2010 - July 2010)
Key Trial Info
Start Date :
January 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
4488 Patients enrolled
Trial Details
Trial ID
NCT02284399
Start Date
January 1 2014
End Date
December 1 2016
Last Update
June 19 2019
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Phoenix Perinatal Associates
Phoenix, Arizona, United States, 85014
2
Long Beach Memorial Medical Center
Long Beach, California, United States, 90801-1428
3
Good Samaritan Hospital
San Jose, California, United States, 95124
4
Presbyterian/St Luke's Hospital
Denver, Colorado, United States, 80218